Liminatus Pharma, Inc. (LIMN) KPIs and segments

LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$2.99+0.22 (+7.94%)

Close on Nov 13, 2026Market cap $200.81MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Liminatus Pharma's business

Coming soon

This tab will track the numbers specific to Liminatus Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?